Clinical Trials Browser

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms, Poxviridae Infections, Vaccinia, Virus Diseases

NCT04764513 2022-03-28

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Phase 1/2 Unknown

20 enrolled

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04004910 2022-03-24

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Phase 1/2 Unknown

170 enrolled

Breast

Breast Neoplasms

NCT05198856 2022-01-20

Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

Phase 1/2 Unknown

106 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04620954 2021-12-01

ORION-02

Phase 1/2 Unknown

31 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT02046187 2021-06-16

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Phase 1/2 Terminated

14 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT03985891 2020-12-17

JSFOL

Phase 1/2 Recruiting

40 enrolled

Gastrointestinal

Colonic Neoplasms

Clinical Trials

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

WU-KONG36

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

SC9/ABX

TD-ENSEMBLE

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

HER-OIC

Morpheus-panBC

SYS6090 Combination Therapy in Advanced Lung Cancer

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

A Study of AK112 in Advanced Malignant Tumors

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies

Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Néo-APBI-01

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

PULSAR Combined With Immunotherapy and Chemotherapy

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

KYANITE-1

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

OPTIMIZE-1

Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Surgery for Relapsed Ovarian Cancer in Precision

AK129 Combination Therapy for Advanced Solid Tumors

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

MESODEC

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

PanC-ASAP

A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

IMAGINE

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

ORION-02

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

JSFOL